Literature DB >> 18533135

Dystrophin and utrophin isoforms are expressed in glia, but not neurons, of the avian parasympathetic ciliary ganglion.

Rachel Blitzblau1, Elizabeth K Storer, Michele H Jacob.   

Abstract

Muscular dystrophy patients often show cognitive impairment, in addition to muscle degeneration caused by dystrophin gene defects. The cognitive impairments lead to speculation that the dystrophin protein family may play a key role at neuronal synapses. Dystrophin regulates the stability of selected GABA(A) receptor subtypes and alpha3-containing nicotinic acetylcholine receptors (nAChRs) at a subset of central GABAergic and peripheral sympathetic nicotinic neuron synapses. Similarly, utrophin, the autosomal homologue of dystrophin, is not required for clustering but indirectly stabilizes muscle-type nAChRs at the neuromuscular junction. We examined dystrophin and utrophin expression and localization in the avian parasympathetic ciliary ganglion (CG) to determine whether these proteins play a general role at neuronal nicotinic synapses. We have determined that full-length utrophin and dystrophin and the short dystrophin isoform Dp116 are the major isoforms expressed in the CG based on immunoblotting and immunolabeling. Unexpectedly, the cytoskeletal proteins were not detected at nicotinic synapses or in CG neurons. They are expressed in myelinating and non-myelinating Schwann cells. Further, utrophin expression developmentally precedes that of dystrophin. The proteins show partially overlapping distributions, but also differential accumulation along the surface membrane of Schwann cells adjacent to neuronal somata versus axonal processes. Our findings are consistent with reports that dystrophin protein family members function in the maintenance of cell-cell interactions and myelination by anchoring the Schwann cell surface membrane to the basal lamina. In contrast, our results differ from those in skeletal muscle and a subset of sympathetic neurons where utrophin and dystrophin localize at nicotinic synapses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18533135      PMCID: PMC2512258          DOI: 10.1016/j.brainres.2008.04.071

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  93 in total

Review 1.  ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins.

Authors:  C P Ponting; D J Blake; K E Davies; J Kendrick-Jones; S J Winder
Journal:  Trends Biochem Sci       Date:  1996-01       Impact factor: 13.807

Review 2.  Dystrophin in the nervous system.

Authors:  H G Lidov
Journal:  Brain Pathol       Date:  1996-01       Impact factor: 6.508

3.  Different utrophin and dystrophin properties related to their vascular smooth muscle distributions.

Authors:  F Rivier; A Robert; G Hugon; D Mornet
Journal:  FEBS Lett       Date:  1997-05-12       Impact factor: 4.124

4.  A G+1-->A transversion at the 5' splice site of intron 69 of the dystrophin gene causing the absence of peripheral nerve Dp116 and severe clinical involvement in a DMD patient.

Authors:  G P Comi; E Ciafaloni; H A de Silva; A Prelle; A Bardoni; C Rigoletto; M Robotti; N Bresolin; M Moggio; F Fortunato
Journal:  Hum Mol Genet       Date:  1995-11       Impact factor: 6.150

5.  Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.

Authors:  B Yang; D Jung; J A Rafael; J S Chamberlain; K P Campbell
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

6.  Dp140: a novel 140 kDa CNS transcript from the dystrophin locus.

Authors:  H G Lidov; S Selig; L M Kunkel
Journal:  Hum Mol Genet       Date:  1995-03       Impact factor: 6.150

7.  A novel dystrophin isoform is required for normal retinal electrophysiology.

Authors:  V N D'Souza; T M Nguyen; G E Morris; W Karges; D A Pillers; P N Ray
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

8.  Dystrophin and its isoforms in a sympathetic ganglion of normal and dystrophic mdx mice: immunolocalization by electron microscopy and biochemical characterization.

Authors:  M E De Stefano; M L Zaccaria; M Cavaldesi; T C Petrucci; R Medori; P Paggi
Journal:  Neuroscience       Date:  1997-09       Impact factor: 3.590

9.  Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice.

Authors:  A E Deconinck; A C Potter; J M Tinsley; S J Wood; R Vater; C Young; L Metzinger; A Vincent; C R Slater; K E Davies
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

10.  Subtle neuromuscular defects in utrophin-deficient mice.

Authors:  R M Grady; J P Merlie; J R Sanes
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

View more
  4 in total

1.  Autologous bone marrow mononuclear cell transplantation in Duchenne muscular dystrophy - a case report.

Authors:  Alok Sharma; Hemangi Sane; Amruta Paranjape; Khushboo Bhagawanani; Nandini Gokulchandran; Prerna Badhe
Journal:  Am J Case Rep       Date:  2014-03-28

2.  Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Azeez Aranmolate; Nathaniel Tse; Holly Colognato
Journal:  BMC Neurosci       Date:  2017-08-14       Impact factor: 3.288

3.  Cellular Transplantation Alters the Disease Progression in Becker's Muscular Dystrophy.

Authors:  Alok Sharma; Amruta Paranjape; Hemangi Sane; Khushboo Bhagawanani; Nandini Gokulchandran; Prerna Badhe
Journal:  Case Rep Transplant       Date:  2013-06-06

Review 4.  Dystrophin Dp116: A yet to Be Investigated Product of the Duchenne Muscular Dystrophy Gene.

Authors:  Masafumi Matsuo; Hiroyuki Awano; Masaaki Matsumoto; Masashi Nagai; Tatsuya Kawaguchi; Zhujun Zhang; Hisahide Nishio
Journal:  Genes (Basel)       Date:  2017-10-02       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.